Alentis Therapeutics
Alentis Therapeutics is a clinical-stage biotech company developing first-in-class anti-Claudin-1 antibodies and ADCs for cancer and fibrosis. Its pipeline includes oncology candidates such as ALE.P02/ALE.P03 and the fibrosis program Lixudebart (ALE.F02).
biotechpharmaceuticals
Open roles
6
+1 in the last 30 days
Posting views
18
in the last 30 days, +17 vs the 30 before. One visitor counts once per posting per day.
Reply rate
Not enough data yet.
Time a posting stays open
38 days
median over 6 postings closed in the last 6 months
Postings added vs. removed
Who they hire
What the company's open postings ask for.